Experimental Evidence for HIV-Associated Phenotypic Reprogramming of CD4⁺ T Cells: An Exploratory Immunological Study

Abstract

BackgroundHuman immunodeficiency virus type 1 (HIV-1) infection is characterized by progressive immune dysfunction, classically attributed to depletion of CD4{square} T lymphocytes. Despite decades of research, the mechanisms underlying the functional deterioration of cellular immunity remain incompletely understood. We hypothesized that, in addition to quantitative CD4{square} T-cell loss, HIV infection may induce phenotypic reprogramming of CD4{square} T cells, resulting in altered surface-marker expression and impaired immunological function. MethodsPeripheral blood samples were obtained from untreated HIV-positive individuals and healthy controls. Flow cytometric immunophenotyping, recombinant HIV-1 p17 stimulation assays, immunofluorescence imaging, ELISPOT analysis of interferon-{gamma} secretion, and CD4{square}/CD8{square}conjugation assays were performed to investigate dynamic changes in T-cell phenotype and function following viral protein exposure. ResultsHIV-positive samples demonstrated progressive reductions in CD4{square} T-cell counts accompanied by corresponding increases in CD8{square} T-cell populations following p17 stimulation, while the combined CD4{square}/CD8{square} T-cell count remained relatively stable. Immunofluorescence analyses identified cells exhibiting simultaneous CD4- and CD8-associated marker expression after prolonged incubation. Functional analyses further demonstrated markedly reduced interferon-{gamma} secretion in the newly identified cell population compared with conventional CD8{square} T cells. Conjugation assays additionally suggested altered cellular interaction patterns between reprogrammed cells and target CD4{square}lymphocytes. ConclusionsThese findings support the hypothesis that chronic HIV infection may be associated with phenotypic reprogramming of CD4{square} T cells rather than simple quantitative depletion alone. Although the underlying molecular mechanisms remain to be established, this exploratory model provides an alternative framework for investigating HIV-associated immune dysfunction and may stimulate future studies using lineage-tracing, single-cell transcriptomics, and epigenetic profiling to evaluate this proposed mechanism.